Longevity Health Holdings (XAGE) shares surged about 70% in extended trading Wednesday after the Nasdaq Hearings Panel granted its request to continue its listing.
Longevity said the decision followed a review of its business developments, financial disclosures, and proposed merger with 20/20 BioLabs on or before Sept. 2.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.